Yantai Dongcheng Pharmaceutical (SHE:002675) unit Andy Center agreed to repurchase a 34.55% stake in Mido (Yantai) Biotechnology for up to 452.3 million yuan.
The price includes the 380-million-yuan investment plus 8% annual compound interest from the investment date to the repurchase date.
After the buyback, Mido (Yantai) Biotechnology will convert capital reserves to boost Andy Center's registered capital by up to 4.3 million, based on a 1.1-billion-yuan valuation.